Numerous animal studies and clinical trials have shown that CCL2/MCP-1 mediates the pathological process of ischemic stroke and that higher serum levels of CCL2 are strongly associated with a high risk of any form of stroke (Huang et al., 2018, Shan et al., 2021, Bernstein and Rom, 2020). Here, CCL2 is linked to stroke disorder.